Dr. Jakobovits is President and CEO of Adicet Bio, Inc. and a Venture Partner at Orbimed Advisors, LLC. Previously Dr. Jakobovits served as President and Founding CEO of Kite Pharma, Inc., a biopharmaceutical company devoted to cancer T cell immunotherapy. During her distinguished career, Dr. Jakobovits has had several director and executive-level positions at other biotech companies, including: Cell Genesys, Inc., Abgenix, Inc. and Agensys, Inc.
At ACGT, Dr. Jakobovits will serve alongside other top scientists to set the strategic direction of the organization and guide grant making. Her expertise in research, development, business and operations, will help ACGT continue its mission of discovering innovative and less-invasive ways of treating and defeating cancer.
“I’m thrilled to be a part of ACGT and its mission,” Dr. Jakobovits said. “Now is a tremendously exciting and optimistic time in oncology — and I look forward to serving on one of the nation’s most innovative foundations alongside the industry’s brightest minds.”